Supply Chain Management
Sourcing & Contract Management
Request for Proposal
Bid Number #: 190607/ME
RFx Name: Smithville Relocation: Research Labs, Offices to 3SCRB Level 02
Open: Sep 15, 2020 8:30 PM
Close: Oct 14, 2020 2:00 PM
Name: Mary E Mueller
The University of Texas MD Anderson Cancer Center
Smithville Relocation: Research Labs, Offices to 3SCRB Level 02 - 190607/ME
Introduction to MD Anderson
MD Anderson is known throughout the world for high-quality cancer care, research, academic programs and prevention services. Since its establishment in 1941, MD Anderson has made major contributions to improve the outlook for cancer patients everywhere.
MD Anderson was one of the first three federally designated comprehensive cancer centers by the National Cancer Act of 1971. A survey of health professionals has routinely ranked MD Anderson as one of the two premier cancer centers in the nation for the past eight years. Over 55,000 persons annually seek care at MD Anderson. The team approach to cancer care, pioneered at MD Anderson, has been strengthened by consolidating specialty clinics into multi-disciplinary care centers that allow patients to receive more ambulatory care and treatment in a single location.
MD Anderson offers one of the largest bone marrow and stem cell transplantation programs, as well as clinical trials to improve existing therapies. Teams of clinical specialists collaborate with scientists on problems of common interest and test theories that shorten the application of better treatment methods. Translational research studies are responsible for the promising field of chemoprevention, which uses synthetic vitamins to reverse pre-malignant lesions and halt the recurrence of some cancers, and for innovative gene therapy strategies being evaluated for several forms ofcancer.
With faculty and staff working in more than 30 buildings in the greater Houston area and in central Texas, MD Anderson is the largest freestanding cancer center in the world. The physical plant covers more than 11 million square feet, featuring the latest equipment and facilities to support growing needs in outpatient and inpatient care, research, prevention and education. It includes inpatient hospital facilities with 571 beds.
Construction projects include the addition of 12 floors that can accommodate more than 300 new inpatient beds in Alkek Hospital on the North Campus; two new research buildings on the South Campus that will house the Center for Advanced Biomedical Imaging Research and Center for Targeted Therapy as part of the McCombs Institute; and MD Anderson's first facility on its Mid Campus, a 25-story building to support current office space and future growth needs.
In addition to its main campus in the Texas Medical Center and two research campuses in Bastrop County, Texas, MD Anderson has developed a number of local, national and international affiliations
PROJECT DESCRIPTION AND SCOPE:
The intent of this project is to convert existing administrative space in 3 South Campus Research Building – 2nd Floor. The new space will be a laboratory space with administrative support areas. The demolition of the existing administrative areas will be complete by a contractor prior to selected GC mobilizing to site. The contract documents issued by Architect will detail the “shell” condition the site should be in when GC mobilizes. Scope of this project is from “Shell” space to laboratory space including, not limited to mechanical, plumbing, electrical, and finishes.
A virtual pre-submittal conference will be held at the date and time described below.
FRIDAY, SEPTEMBER 18, 2020 @ 11:00 AM local time
Zoom meeting website: https://mdacc.zoom.us/j/93087272135?
Meeting ID: 930 8727 2135
Audio: US: +1 346 248 7799 or +1 669 900 6833 or +1 253 215 8782 or +1 312 626 6799
Skype for Business (Lync): https://mdacc.zoom.us/skype/93087272135
Questions related to this RFP must be sent via the information request form. All questions must be received no later than September 22, 2020 4:00 PM. Questions received after this time will not be accepted. Questions will not be answered via telephone. All answers to any questions or inquiries will be posted on the webpage for all Suppliers to access. It is the intent of MD Anderson to respond to all questions and concerns; however, MD Anderson shall reserve the right to decline to respond to any question or concern.
It is important to note that the supplier or suppliers selected to develop MD Anderson's RFP are not automatically qualified to engage with the Institution for purposes of implementing the recommended strategy or solutions. The engagement of contracted services for implementation can, at MD Anderson's discretion, be solicited via a second and separate Request for Proposal.
Standard Riders and Agreements
***Interested suppliers should also note that Subcontracting Opportunities are
probable in connection with this solicitation. Please review the HUB Subcontracting Tip Sheet
***RFx refers to RFP, RFQ, RFI, ITB, etc.